Pay in 4 interest-free payments of $6.01 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
BPC-157 + TB-500 Peptide Blend Synthesized and Lyophilized in Canada by Koi Peptides Domestic Co-Lyophilization at a Canadian Facility BPC-157 and TB-500 are produced on independent solid-phase peptide synthesis runs at Koi's Canadian production partner, each purified to clear the 99% specification before being combined at a 1:1 mass ratio for a single co-lyophilization cycle
A peptide reconstituted in 0.9% saline lacks the preservative needed for multi-dose use, and the peptide will typically aggregate within 3-5 days of regular re-puncture
Type 1 diabetes Those with type 1 diabetes are at a higher risk for other autoimmune disorders such as Coeliac disease or thyroid problems
doi: 10.1515/iss-2017-0010 161
